Clinical trials and population studies have shown that the HPV vaccine is highly effective in preventing infections with the HPV types it targets. For example, Gardasil 9 provides protection against nine HPV types, covering approximately 90% of HPV-related cancers. The vaccine's efficacy is highest when administered before individuals become sexually active, typically recommended for preteens aged 11-12 years.
